Obesity linked to improved survival in kidney cancer

September 5, 2016, Dana-Farber Cancer Institute
This is an image of a weight scale. Credit: CDC/Debora Cartagena

Obesity almost always increases cancer risk and worsens outcomes, but researchers led by scientists at Dana-Farber Cancer Institute report that overweight patients with advanced kidney cancer had significantly longer survival than those who were normal or underweight.

Having a high body mass index (BMI) is a well-established risk factor for clear cell , the most common type of . (BMI is the ratio of weight in kilograms divided by the squared height in meters.)

Yet, paradoxically, the study published in the Journal of Clinical Oncology involving thousands of patients in four databases demonstrated that when overweight individuals developed kidney cancer - especially in its advanced, metastatic form - their disease progressed more slowly and they lived longer than their normal-weight counterparts.

In one cohort of nearly 2,000 patients, the median overall survival of patients with high BMI (overweight or obese) was 25.6 months compared to 17.1 months for patients with low BMI. The mortality rate for the overweight cancer patients was 16 percent less over the course of the study, which began in 2003.

The report's authors, led by senior and corresponding author Toni K. Choueiri, MD, director of the Lank Center for Genitourinary Oncology at Dana-Farber, noted previous research showed that kidney cancer diagnosed in obese patients had less-dangerous pathological characteristics, and when treated with targeted therapies, these patients, even when their disease had spread, had better overall survival.

In the new study, Choueiri and his colleagues, including first author Laurence Albiges, PhD, formerly a visiting scientist at Dana-Farber, now GU Medical Oncology Lead at Institut Gustave Roussy in France, confirmed these findings in four separate databases, which Choueiri said "makes this a very strong study."

The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) provided records on 1,975 patients who had received targeted therapies. Their height and weight were recorded at the initiation of therapy. In a validation set, the scientists also analyzed pooled data on 4.657 patients treated for kidney cancer in clinical trials between 2003 and 2013.

Another dataset, from The Cancer Genome Atlas project, included clinical and genomic information on 324 kidney cancer patients. The fourth database included cancer tissue samples from 146 kidney cancer patients treated at Dana-Farber and other Harvard-affiliated hospitals. . Using these two databases, the investigators searched for molecular differences between the high- and low-BMI patients that might explain why kidney tumors in obese patients were less aggressive and responded better to treatment.

The TGCA analysis didn't reveal any differences in the tumors' DNA, such as gene mutations, that might account for the disparity. But when the scientists looked at gene expression - the rate at which genetic information was being used by the cell to make proteins - they spotted a difference. Expression of a gene called fatty acid synthase (FASN) was found to be decreased in patients with high BMI compared to normal weight patients. FASN is key enzyme in lipogenesis - cells' production of fatty acids - and overexpression of FASN has previously been found in many types of cancer - so much so that FASN has been called a metabolic oncogene. FASN has been associated with poor prognosis in several types of cancer, including kidney cancer.

Since FASN expression was decreased, or "downregulated," in overweight and obese kidney cancer patients, that could explain why these individuals fared better than those who were of normal weight and had increased FASN gene expression. Why FASN is downregulated in isn't yet known, but the authors of the study say the results provide a rationale for experiments aimed at inhibiting FASN expression in kidney cancer - regardless of their BMI - in an effort to improve outcomes. FASN inhibitors, including some derived from natural products, have been in development for several years and are considered a promising approach to cancer treatment.

"We plan to test FASN inhibitors in an animal model as a possible therapy for kidney cancer," said Choueiri.

Explore further: Study finds surgery can lengthen survival of metastatic kidney cancer patients

Related Stories

Study finds surgery can lengthen survival of metastatic kidney cancer patients

June 20, 2016
Surgery to remove a cancerous kidney can often lengthen the lives of patients receiving targeted therapy for metastatic kidney cancer, but only about three in ten such patients undergo the procedure, according to a new study ...

New drug improves outcome in treatment resistant kidney cancer

September 28, 2015
A new drug has been found superior to current treatments in slowing the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had kept it in check, according to results from a ...

Higher survival rate for overweight colorectal cancer patients than normal-weight patients

May 19, 2016
Overweight colorectal cancer patients were 55 percent less likely to die from their cancer than normal-weight patients who have the disease, according to a new Kaiser Permanente study published today in JAMA Oncology.

Researchers use genetics to probe immune system's role in fighting cancer

August 25, 2016
To better understand the immune system's role in the fight against cancer, University of North Carolina Lineberger Comprehensive Cancer Center researchers have searched thousands of tumors for genetic signatures that might ...

Prevalence of estrogen receptor mutations in patients with metastatic breast cancer

August 11, 2016
A new study published online by JAMA Oncology examines the prevalence and significance of estrogen receptor mutations in patients with metastatic breast cancer.

Thin colorectal cancer patients have shorter survival than obese patients

July 1, 2015
Although being overweight with a high body-mass index (BMI) has long been associated with a higher risk for colorectal cancer, thinner patients might not fare as well after treatment for advanced cancer, according to a new ...

Recommended for you

Metastatic cancer gorges on fructose in the liver

April 26, 2018
Biomedical engineers at Duke University have demonstrated that metastatic cancer cells can reprogram their metabolism to thrive in new organs. Specifically, the research shows that cells originating from colorectal cancer ...

Breast cancer genes a real risk for men, too

April 26, 2018
(HealthDay)—Few American men are screened for gene mutations that can greatly increase their risk of breast and other types of cancers, a new study reveals.

Largest-ever study of thyroid cancer genetics finds new mutations, suggests immunotherapy

April 26, 2018
University of Colorado Cancer Center researchers recently completed the largest-ever study of thyroid cancer genetics, mining the data of 583 patient samples of advanced differentiated thyroid cancer and 196 anaplastic thyroid ...

Molecular culprit behind virus-mediated chronic inflammation and cancers identified

April 26, 2018
Within cells infected by Kaposi sarcoma herpesvirus (KSHV), the human protein CADM1 interacts with viral proteins to promote chronic inflammation, which plays a major role in the development of cancers caused by KSHV. Richard ...

PARP-1 may be key to effectiveness of PARP inhibitors, and now researchers can image it

April 26, 2018
Penn Medicine researchers have used CRISPR/Cas9 gene editing technology to isolate a key genetic feature that could cause resistance to PARP inhibitors in patients with ovarian cancer—and they've also proven they have a ...

Blood cancer precursor found in 9/11 firefighters

April 26, 2018
A study in today's issue of JAMA Oncology reports that New York City firefighters exposed to the 9/11 World Trade Center disaster site face an increased risk for developing myeloma precursor disease (MGUS), which can lead ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.